BETA · In development—Rankings and features improve every week.Spotted an error?Tell us →
Sign in / Register

Prenuvo

Active#6 worldwide · Imaging & medical AI

Estimated valuation · Imaging & medical AI · United States

Runs a network of clinics offering whole-body MRI screening scans, read by radiologists with AI support, to detect cancers and other conditions early in consumers.

HQUnited States
Last roundSeries B · Feb 2025

Estimated valuation

AI · Imaging & medical AI ranking (worldwide)
≈ USD 620MUSD 500–770M · Hundreds of M$
Anchor
Last known equity round: Series B · USD 120M · Feb 2025

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Imaging & medical AI · worldwideTop 25#6Edition 0 · Oct 202626 Apr 2027
Rank historyOct 2026 · #6 Imaging & medical AIFirst edition: no movements yet.

Funding history

DateRoundAmountTypeInvestors
Feb 2025Series BUSD 120MEquityForerunner Ventures, Left Lane Capital, Felicis

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Prenuvo as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $620MUndervalued or overvalued?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in imaging & medical ai

Full imaging & medical ai ranking →

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.